Consolidation With Campath-1H After FMC Induction in Patients With T-cell Chronic Lymphocytic Leukemia
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Alemtuzumab (Primary) ; Cyclophosphamide; Fludarabine; Mitoxantrone
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 10 Jul 2007 Status changed from recruiting to in progress.
- 18 Nov 2006 New trial record.